id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-D-0094-0002,FDA,FDA-2002-D-0094,"Guidance for the Public, FDA Advisory Committee Members, and FDA Staff: Public Availability of Advisory Committee Members' Financial Interest Information and Waivers, October 2007",Other,GDL-Guidance (Supporting and Related Materials),2007-10-31T04:00:00Z,2007,10,,,2010-08-06T23:49:08Z,,0,0,090000648048e4a2
FDA-2002-D-0094-0003,FDA,FDA-2002-D-0094,"Draft Guidance for the Public, Food and Drug Administration Advisory Committee Members, and Food and Drug Administration Staff: Public Availability of Advisory Committee Members Financial Interest Information and Waivers; Availability",Notice,NAD-Notice of Availability of Data,2007-10-31T04:00:00Z,2007,10,2007-10-31T04:00:00Z,2008-01-01T04:59:59Z,2010-08-06T23:52:22Z,,0,0,090000648048e4a5